The New Orleans BioInnovation Center is embarking on a new campaign to lure bio industry workers back to the city.
A method of delivering chemotherapy drugs into a deadly type of brain tumor extended the lives of patients in early clinical trials.
Clarient is launching a new breast cancer test that helps physicians assess the probability of a patient’s cancer returning.
Eight studies presented this week at the American Urological Association Annual Meeting suggest that Gen-Probe’s investigational test for the prostate cancer gene PCA3 may address some of the major challenges faced by urologists when diagnosing the disease.
Some patients fear injections so much that they avoid getting proper medical treatment, sometimes with life-threatening results. Transdermal patches, which administer drugs through the skin, could make the bite of the needle a mere unpleasant memory.
Solid tumors represent 85 percent of all cancers, creating a huge clinical need for localized, site-specific cancer treatment. Inovio Medical Corporation of San Diego is developing DNA-based vaccines that harness the body’s immune system to prevent and treat chronic diseases such as cancer and HIV.
Center have created a test that could help doctors identify which breast cancer patients need aggressive therapy. The study, published in the online version of Clinical Cancer Research, could prevent many women from undergoing unnecessary chemotherapy or radiation treatment.
A common prostate-cancer screening test may be largely ineffective, according to two new studies. Scientists in the U.S. and Europe found that the PSA blood test saves few lives and leads to unnecessary treatments for large numbers of men.